Profil
Einar Pontén is currently the Head-Business Development at Lipum AB since 2016.
Previously, he worked as the Managing Director at Merck SeQuant AB and as the Head-Research & Development at Anolytech AB. Dr. Pontén holds a doctorate degree from Umea Universitet.
Aktive Positionen von Einar Pontén
| Unternehmen | Position | Beginn |
|---|---|---|
| LIPUM AB | Corporate Officer/Principal | 01.12.2023 |
Ehemalige bekannte Positionen von Einar Pontén
| Unternehmen | Position | Ende |
|---|---|---|
Merck SeQuant AB
Merck SeQuant AB Medical SpecialtiesHealth Technology Provides liquid chromatography technology and other related products | Vorstandsvorsitzender | 02.01.2011 |
Anolytech AB
Anolytech AB Wholesale DistributorsDistribution Services Provides disinfection of livestock farming and food production solutions | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Einar Pontén
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Merck SeQuant AB
Merck SeQuant AB Medical SpecialtiesHealth Technology Provides liquid chromatography technology and other related products | Health Technology |
Umea Universitet
Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anolytech AB
Anolytech AB Wholesale DistributorsDistribution Services Provides disinfection of livestock farming and food production solutions | Distribution Services |
Lipum AB
Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
















